Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine
暂无分享,去创建一个
T. VanderWeele | H. Nan | E. Giovannucci | S. Ogino | R. Nishihara | Molin Wang | A. Nishi | P. Lochhead | Z. Qian | Xuehong Zhang | Kana Wu | Kazuki Yoshida | D. Milner | A. Chan | A. Field | C. Camargo | Michelle A. Williams | A. Chan | M. Williams | K. Wu | Reiko Nishihara | Michelle A Williams
[1] Shuji Ogino,et al. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.
[2] S. Ogino,et al. Molecular classification and correlates in colorectal cancer. , 2008, The Journal of molecular diagnostics : JMD.
[3] S. Ogino,et al. Aspirin Use and Survival After Diagnosis of Colorectal Cancer , 2009 .
[4] S. Ogino,et al. Aspirin Use and Survival After Diagnosis of Colorectal Cancer , 2009 .
[5] D. Spiegelman,et al. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. , 2009, Gastroenterology.
[6] N. Chatterjee,et al. Analysis of cohort studies with multivariate and partially observed disease classification data. , 2010, Biometrika.
[7] Shuji Ogino,et al. Editorial Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: the Evolving Field of Molecular Pathological Epidemiology , 2022 .
[8] E. Giovannucci,et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field , 2010, Gut.
[9] J. Meyerhardt,et al. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. , 2011, Journal of the National Cancer Institute.
[10] R. Goldbohm,et al. Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP) , 2011, PloS one.
[11] P. Febbo,et al. NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.
[12] E. Giovannucci,et al. Statin Use and Colorectal Cancer Risk According to Molecular Subtypes in Two Large Prospective Cohort Studies , 2011, Cancer Prevention Research.
[13] Martha L. Slattery,et al. CpG Island Methylation in Colorectal Cancer: Past, Present and Future , 2011, Pathology research international.
[14] Y. Sakamoto,et al. Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma , 2012, Annals of Surgical Oncology.
[15] G. Dranoff,et al. Cancer immunology—analysis of host and tumor factors for personalized medicine , 2011, Nature Reviews Clinical Oncology.
[16] Charles J. Kahi,et al. Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel , 2012, The American Journal of Gastroenterology.
[17] J. Cerhan,et al. Postmenopausal Hormone Therapy and Colorectal Cancer Risk in Relation to Somatic KRAS Mutation Status among Older Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[18] T. Sellers,et al. Integrative cancer epidemiology--the next generation. , 2012, Cancer discovery.
[19] F. Marincola,et al. Cancer classification using the Immunoscore: a worldwide task force , 2012, Journal of Translational Medicine.
[20] Ronglai Shen,et al. Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers , 2012, Clinical Cancer Research.
[21] Reiko Nishihara,et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. , 2012, The New England journal of medicine.
[22] R. Luben,et al. Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC‐Norfolk study , 2012, The Journal of pathology.
[23] J. Koshiol,et al. Can tissue-based immune markers be used for studying the natural history of cancer? , 2012, Annals of epidemiology.
[24] R. Ali,et al. Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms , 2012, Nature Reviews Clinical Oncology.
[25] Shuji Ogino,et al. Colorectal cancer: a tale of two sides or a continuum? , 2012, Gut.
[26] R. Goldbohm,et al. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. , 2012, International journal of epidemiology.
[27] P. A. van den Brandt,et al. The CpG island methylator phenotype in colorectal cancer: progress and problems. , 2012, Biochimica et biophysica acta.
[28] F. Grizzi,et al. Adaptive and Innate Immunity, Non Clonal Players in Colorectal Cancer Progression , 2012 .
[29] Shuji Ogino,et al. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine , 2012, Expert review of molecular diagnostics.
[30] Y. Pawitan,et al. Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X , 2012, Modern Pathology.
[31] Andrew H. Beck,et al. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. , 2012, American journal of epidemiology.
[32] Levi Waldron,et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum , 2012, Gut.
[33] E. Giovannucci,et al. Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle. , 2012, International journal of epidemiology.
[34] J. Hardwick,et al. Cholesterol metabolism and colorectal cancers. , 2012, Current opinion in pharmacology.
[35] J. Swinnen,et al. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. , 2013, Progress in lipid research.
[36] Nita Ahuja,et al. The CpG island methylator phenotype: what's in a name? , 2013, Cancer research.
[37] Alexander Meissner,et al. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease , 2013, Modern Pathology.
[38] N. Cho,et al. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location , 2013, British Journal of Cancer.
[39] S. Ogino,et al. The merits of subtyping obesity: one size does not fit all. , 2013, JAMA.
[40] P. A. van den Brandt,et al. The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach , 2013, Current Nutrition Reports.
[41] Reiko Nishihara,et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.
[42] F. Bazzoli,et al. Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention , 2013, International journal of molecular sciences.
[43] Kjetil Søreide,et al. Molecular Pathways and Cellular Metabolism in Colorectal Cancer , 2013, Digestive Surgery.
[44] S. Kaufmann,et al. Diagnostic biomarkers are hidden in the infected host’s epigenome , 2013, Expert review of molecular diagnostics.
[45] R. Kaliaperumal,et al. Conventional and nanotechniques for DNA methylation profiling. , 2013, The Journal of molecular diagnostics : JMD.
[47] E. Livingston,et al. New insights on bariatric surgery outcomes. , 2013, JAMA.
[48] F. Sinicrope,et al. Aspirin and Colorectal Cancer: Back to the Future , 2013, Clinical Cancer Research.
[49] Aung Ko Win,et al. Family History of Colorectal Cancer in BRAF p.V600E-Mutated Colorectal Cancer Cases , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[50] J. Potter,et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. , 2013, Cancer research.
[51] W. Willett,et al. Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. , 2013, American journal of epidemiology.
[52] C. Carlson,et al. Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. , 2013, International journal of molecular epidemiology and genetics.
[53] N. Ajami,et al. Potential role of gastrointestinal microbiota composition in prostate cancer risk , 2013, Infectious Agents and Cancer.
[54] Aung Ko Win,et al. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features , 2013, Modern Pathology.
[55] The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium. , 2013, American journal of epidemiology.
[56] D. Kerr,et al. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] A. A. de Araújo,et al. Lifestyle and family history influence cancer prognosis in Brazilian individuals. , 2013, Pathology, research and practice.
[58] K. Jirström,et al. Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability , 2014, BMC Cancer.
[59] M. Kloor,et al. Body Mass Index and Microsatellite Instability in Colorectal Cancer: A Population-based Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[60] M. Ribeiro,et al. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. , 2013, World journal of gastroenterology.
[61] M. Woods,et al. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype , 2014, British Journal of Cancer.
[62] N. Shaheen. Editorial: What Is Behind the Remarkable Increase in Esophageal Adenocarcinoma? , 2014, The American Journal of Gastroenterology.
[63] S. Thibodeau,et al. Establishment of the Cancer Prevention Study II Nutrition Cohort Colorectal Tissue Repository , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[64] J. Meyerhardt,et al. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology , 2014, Oncogene.
[65] Thomas Mikeska,et al. DNA Methylation Biomarkers: Cancer and Beyond , 2014, Genes.
[66] R. Bostick,et al. Challenges and Opportunities in International Molecular Cancer Prevention Research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report , 2014, Cancer Epidemiology, Biomarkers and Prevention.
[67] R. van Winkel. Aetiological stratification as a conceptual framework for gene-by-environment interaction research in psychiatry , 2014, Epidemiology and Psychiatric Sciences.
[68] Seth D. Crockett,et al. Risk Factors for Serrated Polyps of the Colorectum , 2014, Digestive Diseases and Sciences.
[69] A. L. Cisyk,et al. Characterizing the prevalence of chromosomal instability in interval colorectal cancer , 2014 .
[70] Han Wu,et al. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis , 2014, Gut.
[71] P. A. van den Brandt,et al. Body Size, Physical Activity, Early-Life Energy Restriction, and Associations with Methylated Insulin-like Growth Factor–Binding Protein Genes in Colorectal Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[72] R. Malekzadeh,et al. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. , 2014, World journal of gastroenterology.
[73] F. Coppedè. The role of epigenetics in colorectal cancer , 2014, Expert review of gastroenterology & hepatology.
[74] E. Giovannucci,et al. Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions , 2014, The American Journal of Gastroenterology.
[75] Hiromu Suzuki,et al. Biological significance of the CpG island methylator phenotype. , 2014, Biochemical and biophysical research communications.
[76] Vojtech Huser,et al. Developing genomic knowledge bases and databases to support clinical management: current perspectives , 2014, Pharmacogenomics and personalized medicine.
[77] Witvliet Mi. World Health Survey: A Useful Yet Underutilized Global Health Data Source , 2014 .
[78] R. Sinha,et al. A prospective study of serum metabolites and colorectal cancer risk , 2014, Cancer.
[79] R. Wolff,et al. An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. , 2014, Cancer epidemiology.
[80] E. Giovannucci,et al. Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD) , 2014, Science Translational Medicine.
[81] E. Giovannucci,et al. Environmental Exposure and Tumor Heterogeneity in Colorectal Cancer Risk and Outcomes , 2014, Current Colorectal Cancer Reports.
[82] K. Jirström,et al. Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker , 2014, Diagnostic Pathology.
[83] E. Jordanova,et al. Molecular Backgrounds of ERAP1 Downregulation in Cervical Carcinoma , 2015, Analytical cellular pathology.
[84] V. Seshan,et al. Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer , 2015, Cancer Medicine.
[85] C. Huttenhower,et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. , 2015, JAMA oncology.
[86] Aung Ko Win,et al. Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[87] J. Cerhan,et al. Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[88] Andrew H. Beck,et al. Proceedings of the third international molecular pathological epidemiology (MPE) meeting , 2017, Cancer Causes & Control.
[89] S. Ogino,et al. A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. , 2015, American journal of epidemiology.
[90] K. Sheahan,et al. Estrogen Receptors and Their Implications in Colorectal Carcinogenesis , 2015, Front. Oncol..
[91] E. Giovannucci,et al. Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability. , 2015, Journal of the National Cancer Institute.
[92] C. Ulrich,et al. Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally , 2014, Journal of the National Cancer Institute.
[93] E. Giovannucci,et al. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status , 2015, Gut.
[94] Jun Yu,et al. Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer , 2015, International journal of molecular sciences.
[95] K. Søreide,et al. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. , 2015, Cancer letters.
[96] Łukasz Szylberg,et al. Serrated Polyps and Their Alternative Pathway to the Colorectal Cancer: A Systematic Review , 2015, Gastroenterology research and practice.
[97] I. Kawachi,et al. Lifecourse epidemiology and molecular pathological epidemiology. , 2015, American Journal of Preventive Medicine.
[98] Peter W. Laird,et al. Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[99] C. Chua,et al. Addressing the needs of colorectal cancer survivors: current strategies and future directions , 2015, Expert review of anticancer therapy.
[100] Andrew H. Beck,et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression , 2015, Modern Pathology.